Exicure Inc (XCUR)
Fair Value43.1% Upside
Undervalued
Market Cap5.827 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Femasys Inc (FEMY)
Fair Value36.8% Upside
Undervalued
Market Cap10.971 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value22.0% Upside
Undervalued
Analyst118.2% Upside
Market Cap113.1 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Fulcrum Therapeutics Inc (FULC)
Fair Value32.0% Upside
Undervalued
Analyst-0.4% Downside
Market Cap280.8 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Gain Therapeutics Inc (GANX)
Fair Value52.1% Upside
Bargain
Analyst650.0% Upside
Market Cap41.915 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
GeneDx Holdings Corp (WGS)
Fair Value-12.8% Downside
Fair
Analyst45.3% Upside
Market Cap1.919 B
P/E—
Yield0.0%
HealthGood
NASDAQ
GH Research PLC (GHRS)
Fair Value-5.1% Downside
Fair
Analyst132.6% Upside
Market Cap1.266 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Goodrx Holdings Inc (GDRX)
Fair Value49.6% Upside
Undervalued
Analyst13.2% Upside
Market Cap1.191 B
P/E73.3x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Momentum Stocks
High-Beta Momentum
Gossamer Bio Inc (GOSS)
Fair Value39.7% Upside
Undervalued
Analyst912.7% Upside
Market Cap57.616 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Greenwich Lifesciences Inc (GLSI)
Fair Value-7.1% Downside
Fair
Analyst289.1% Upside
Market Cap215 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
GRI Bio Inc (GRI)
Fair Value26.5% Upside
Undervalued
Market Cap3.388 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Guardant Health Inc (GH)
Fair Value-25.2% Downside
Overvalued
Analyst31.8% Upside
Market Cap20.59 B
P/E—
Yield0.0%
HealthGood
NASDAQ
Harmony Biosciences Holdings (HRMY)
Fair Value53.3% Upside
Bargain
Analyst48.1% Upside
Market Cap1.907 B
P/E10.7x
Yield0.0%
HealthGreat
NASDAQ
HCW Biologics Inc (HCWB)
Fair Value46.2% Upside
Undervalued
Market Cap2.326 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Health Catalyst Inc (HCAT)
Fair Value22.4% Upside
Undervalued
Analyst17.8% Upside
Market Cap112.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
High Tide Inc (HITI)
Fair Value21.6% Upside
Undervalued
Analyst77.4% Upside
Market Cap235.4 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Humacyte Inc (HUMA)
Fair Value60.4% Upside
Bargain
Analyst310.4% Upside
Market Cap109.9 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Hyperfine Inc (HYPR)
Fair Value40.3% Upside
Undervalued
Analyst195.6% Upside
Market Cap72.686 M
P/E—
Yield0.0%
HealthFair
NASDAQ
I Mab (NBP)
Fair Value95.3% Upside
Bargain
Analyst854.5% Upside
Market Cap105.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value5.6% Upside
Fair
Analyst68.2% Upside
Market Cap2.964 B
P/E—
Yield0.0%
HealthFair
NASDAQ
IM Cannabis Corp (IMCC)
Fair Value71.2% Upside
Bargain
Market Cap977.622 K
P/E—
Yield0.0%
HealthWeak
NASDAQ
ImageneBio Inc (IMA)
Fair Value16.4% Upside
Fair
Analyst332.2% Upside
Market Cap47.279 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immatics NV (IMTX)
Fair Value-2.5% Downside
Fair
Analyst165.4% Upside
Market Cap844.7 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immuneering Corp (IMRX)
Fair Value60.5% Upside
Bargain
Analyst404.5% Upside
Market Cap218.3 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value23.7% Upside
Undervalued
Analyst120.9% Upside
Market Cap1.463 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunome Inc (IMNM)
Fair Value8.1% Upside
Fair
Analyst97.3% Upside
Market Cap2.113 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Immunovant Inc (IMVT)
Fair Value-3.7% Downside
Fair
Analyst72.2% Upside
Market Cap5.864 B
P/E—
Yield0.0%
HealthFair
NASDAQ
In8bio Inc (INAB)
Fair Value52.6% Upside
Bargain
Analyst743.4% Upside
Market Cap8.182 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value1.9% Upside
Fair
Analyst285.4% Upside
Market Cap262.2 M
P/E—
Yield0.0%
HealthFair
NASDAQ
InMed Pharmaceuticals Inc (INM)
Fair Value-10.3% Downside
Fair
Market Cap8.777 M
P/E—
Yield0.0%
HealthFair
NASDAQ
InMode Ltd (INMD)
Fair Value49.7% Upside
Undervalued
Analyst20.6% Upside
Market Cap770.2 M
P/E9.9x
Yield0.0%
HealthGreat
NASDAQ
INmune Bio Inc (INMB)
Fair Value23.7% Upside
Undervalued
Analyst493.2% Upside
Market Cap36.136 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Innate Pharma SA (IPHA)
Fair Value11.4% Upside
Fair
Analyst376.2% Upside
Market Cap131.7 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
InnovAge Holding Corp (INNV)
Fair Value-4.2% Downside
Fair
Analyst32.0% Upside
Market Cap1.24 B
P/E137.9x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Low-Float Small-Cap Momentum Stocks
High-Growth Small-Cap Stocks
Instil Bio Inc (TIL)
Fair Value30.5% Upside
Undervalued
Analyst0.1% Upside
Market Cap47.406 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Intelligent Bio Solutions Inc (INBS)
Fair Value39.1% Upside
Undervalued
Analyst581.8% Upside
Market Cap5.328 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Inventiva Sa (IVA)
Fair Value-30.1% Downside
Overvalued
Analyst318.7% Upside
Market Cap890.9 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Invivyd Inc (IVVD)
Fair Value20.3% Upside
Undervalued
Market Cap172.4 M
P/E—
Yield0.0%
HealthGood
NASDAQ
INVO Fertility Inc (IVF)
Fair Value20.2% Upside
Undervalued
Market Cap2.421 M
P/E—
Yield0.0%
HealthFair
NASDAQ
ISpecimen Inc (ISPC)
Fair Value27.6% Upside
Undervalued
Market Cap2.035 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-7.7% Downside
Fair
Analyst255.5% Upside
Market Cap896.7 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Janux Therapeutics Inc (JANX)
Fair Value28.5% Upside
Undervalued
Analyst99.7% Upside
Market Cap981.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value2.4% Upside
Fair
Analyst648.6% Upside
Market Cap56.18 M
P/E—
Yield0.0%
HealthWeak
NASDAQ
Keros Therapeutics Inc (KROS)
Fair Value53.5% Upside
Bargain
Analyst109.9% Upside
Market Cap187.4 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-36.9% Downside
Overvalued
Analyst33.7% Upside
Market Cap5.709 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Korro Bio Inc (KRRO)
Fair Value-11.7% Downside
Fair
Analyst37.1% Upside
Market Cap216.9 M
P/E—
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Momentum
KORU Medical Systems Inc (KRMD)
Fair Value7.9% Upside
Fair
Analyst106.3% Upside
Market Cap139.9 M
P/E—
Yield0.0%
HealthGood
NASDAQ
Kymera Therapeutics Inc (KYMR)
Fair Value-27.8% Downside
Overvalued
Analyst12.8% Upside
Market Cap10.938 B
P/E—
Yield0.0%
HealthFair
NASDAQ
Lantern Pharma Inc (LTRN)
Fair Value40.2% Upside
Undervalued
Market Cap6.801 M
P/E—
Yield0.0%
HealthWeak
NASDAQ